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Abstract
Coxsackievirus B3, a cytopathic virus in the family Picornaviridae, induces degenerative changes in host cell morphology. Here we
demonstrate cytochrome c release and caspases-2, -3, -6, -7, -8, and -9 processing. Enforced Bcl-2 and Bcl-xL expression markedly reduced
release of cytochrome c, presentation of the mitochondrial epitope 7A6, and depressed caspase activation following infection. In
comparison, cell death using TRAIL ligand caused caspase-8 processing prior to cytochrome c release and executioner caspases and cell
death was only partially rescued by Bcl-2 and Bcl-xL overexpression. Disruption of the mitochondrial inner membrane potential following
CVB3 infection was not inhibited by zVAD.fmk treatment. Bcl-2 or Bcl-xL overexpression or zVAD.fmk treatment delayed the loss of host
cell viability and decreased progeny virus release following infection. Our data suggest that mitochondrial release of cytochrome c may be
an important early event in caspase activation in CVB3 infection, and, as such, may contribute to the loss of host-cell viability and progeny
virus release.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Coxsackievirus B3 (CVB3) is an enterovirus of the fam-
ily Picronaviridae, which can infect both murine and hu-
man hosts. In permissive tissue culture cells, or in vivo
tissues such as the myocardium and liver, infection results
in cellular degenerative changes observable by light and
electron microscopy (Enders, 1954; McManus et al., 1993;
Ukimura et al., 1997; Klingel et al., 1998) with eventual loss
of cell viability.
At least two stages of proteolytic events occur within
target cells following viral receptor binding, genome inter-
nalization, and protein translation. The picornaviral pro-
teases have been shown to directly cleave multiple host
proteins early in infection including regulatory proteins in-
volved in host transcription and translation (Etchison et al.,
1982; Clark et al., 1993; Yalamanchili et al., 1996, 1997a,
1997b, 1997c and the cytoskeleton (Badorff et al., 1999).
Later during the virus life cycle, caspases are activated,
resulting in degradation of substrates including poly(ADP-
ribose) polymerase (PARP) and DNA fragmentation factor
(Carthy et al., 1998). Caspases do not appear to be primarily
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responsible for the characteristic architectural degeneration,
or cytopathic effect (CPE) (Carthy et al., 1998). Events such
as caspase processing and cleavage of substrates (Carthy et
al., 1998), substrate phosphorylation (Huber et al., 1997),
and early and late calcium influx (van Kuppeveld et al.,
1997; Li et al., 1999) suggest that cells retain a capacity for
multiple functions following induction of CPE. Thus, con-
densed, smooth-surfaced, rounded cells consistent with CPE
appear to still be viable, although damaged.
Apoptosis can occur through either extrinsic receptor- or
intrinsic mitochondria-mediated pathways or both.
Caspase-8 is commonly associated with death receptor sig-
naling (Muzio et al., 1996), caspase-2 and -9 with mito-
chondrial signaling (Li et al., 1997), and caspase-10 with
granzyme B signaling (Talanian et al., 1997).
Ligation of death ligands such as Fas and tumor necrosis
factor related apoptosis-inducing ligand (TRAIL) with their
appropriate receptors results in the formation of a death-
inducing signaling complex (DISC) at the plasma mem-
brane. Caspase-8 associates with surface receptor death in-
ducing signaling complexes, and to a lesser extent
caspase-3, and has also been shown to amplify apoptosis
through the mitochondria by cleavage of Bid to truncated-
Bid (Bossy-Wetzel and Green, 1999; Li et al., 1998; Cromp-
ton, 2000). Bid cleavage results in cytochrome c (cyt c)
release, caspase-9 activation, and further amplification of
the death proteolytic cascade. It has been shown that cyt c
release may occur through Bid-mediated intramembranous
oligomerization of proapoptosis Bcl-2 family members, Bak
(Wei et al., 2000) or Bax (Eskes et al., 2000; von Ahsen et
al., 2000; Desagher et al., 1999). Caspase-3, -6, and -7 are
considered executioner caspases and their activation results
in processing of numerous cellular proteins at internal as-
partic acid residues which, in turn, results in an apoptotic
phenotype (Nicholson and Thornberry, 1997).
Mitochondria have increasingly become recognized as
important organelles in regulating life or death of cells
(Ravagnan et al., 2002). Cellular stress can trigger apoptosis
through degenerative mitochondrial alterations which may
occur in a caspase-2-dependent manner (Lassus et al.,
2002). Several prominent alterations occur to mitochondria
during apoptosis that include the release of intermembrane
space molecules, changes in the membrane potential, ionic
changes, and more. Compromise of mitochondrial perme-
ability can release sequestered proapoptotic molecules such
as cyt c (Liu et al., 1996), Smac/DIABLO (Verhagen et al.,
2000; Du et al., 2000), HtrA2/Omi (Hegde et al., 2002;
Martins et al., 2002; Suzuki et al., 2001; Verhagen et al.,
2002), Endo G (Li et al., 2001), apoptosis-inducing factor
(AIF; Susin et al, 1999b), procaspase-9 (Susin et al., 1999a),
and others. The best characterized of these, cyt c, in the
cytosol, functions as a cofactor and in the presence of
Apaf-1, caspase-9, and dATP can form an apoptosome to
autocatalyse caspase-9, thereby leading to activation of
downstream caspases (Li et al., 1997).
The Bcl-2 proteins are central regulators of mitochon-
drial permeability and release of proapoptotic molecules.
Bcl-2 and Bcl-xL are antiapoptotic members localized in the
mitochondrial and endoplasmic reticular membranes, as
well as in the nuclear envelope. In the mitochondria, Bcl-2
and Bcl-xL preserve mitochondrial integrity and prevent the
subsequent release of apoptogenic molecules (Liu et al.,
1996; Kluck et al., 1997; Yang et al., 1997).
In this study, we demonstrate, for the first time, that cyt
c is released from the intermitochondrial membrane space
followed by activation of caspase-9 and downstream effec-
tor caspases. Overexpression of Bcl-2 and Bcl-xL, which
blocked cyt c release, completely inhibited caspase cleav-
age, activity, and substrate cleavage following CVB3 infec-
tion, which suggests that such activity occurs downstream
of mitochondrial permeability alteration. CVB3 infection in
HeLa cells overexpressing Bcl-2 or Bcl-xL, or treated with
zVAD.fmk, is associated with decreased cell death and
progeny virus release, although there is no protection from
early cytopathic changes, including cell rounding and de-
tachment.
Results
CVB3 infection leads to cyt c release and activation of
multiple caspases
To explore the mechanisms by which CVB3 infection-
induced apoptosis occurs, HeLa cells were CVB3- or sham-
infected at a multiplicity of infection (m.o.i.) of 10 and
examined for processing and activation of caspases and
downstream targets at 0 to 14 h following infection. Fol-
lowing CVB3 infection, cyt c is release into the cytosol
(s-100 cell lysate) and caspase-9 is cleaved beginning at 8 h
(Fig. 1A). Subsequently, caspases-2, -3, -6, -7, and -8 are
processed 10 to 14 h following CVB3 infection of HeLa
cells (Fig. 1B). Caspase activation is confirmed by cleavage
of lamin A/C and PARP, substrates of caspase-6 and
caspase-3, respectively (Fig. 1B). Cyt c release and subse-
quent caspase activation raises the possibility that the ob-
served apoptosis is triggered at the mitochondria following
CVB3 infection.
As a comparative model of receptor-mediated apoptosis,
HeLa cells were exposed to TRAIL (150 ng/ml) in the
presence and absence of zVAD.fmk. Cells were collected
from 0 to 5 h and cytosolic extracts and examined for cyt c
release and total cell lysates were separated by SDS–PAGE
and immunoblotted for antibodies for caspase-2, -3, -6, -7,
-8, -9, and PARP and lamin A/C. We found that TRAIL
induced caspase-8 processing followed by processing of
subsequent executioner caspases and their substrates (Fig.
1C). Treatment with zVAD.fmk prevented cyt c release and
caspase processing; thus, such events are indeed caspase-
dependent.
To determine whether cardiac myocytes also activate
caspases following CVB3 infection, HL-1 (murine atrial
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Fig. 1. Cytochrome c release and processing of multiple caspases following CVB3 infection. HeLa cells were infected with CVB3 (m.o.i. 10) and harvested
0–14 h postinfection. Cytosolic extracts were separated by SDS–PAGE, and immunoblot analysis was performed using antibodies directed against the
caspases and their substrates. (A) Cytochrome c is released and caspase-9 is cleaved following CVB3 infection. (B) Downstream cleavage of multiple
caspases and substrates PARP and Lamin occurs beginning 10–14 h following CVB3 infection. (C) Cytochrome c release, cleavage of multiple caspases,
and PARP occur following exposure to TRAIL (150 ng/ml) and zVAD.fmk. Caspase processing can be detected by either disappearance of the proform or
appearance of a cleavage product, or both. (D) HL-1 (murine atrial cardiomyocyte) cells were infected with CVB3 (m.o.i. 100) and harvested 0–9 h
postinfection. Caspase-3 cleavage was observed to increase at 7–9 h following infection (positive and negative controls are activated and nonactivated Jurkat
cell lysates, respectively).
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cardiomyocyte) cell lysates were probed for the 17-kDa
caspase-3 cleavage product. An increase in caspase-3 cleav-
age product was observed 7–9 h postinfection (Fig. 1D).
Overexpression of Bcl-2 and Bcl-xL blocks CVB3-induced
cyt c release and activation of caspases
Bcl-2 and Bcl-xL are antiapoptotic molecules which reg-
ulate mitochondrial permeability and release of cyt c into
the cytosol. Neo (vector only) and antiapoptotic Bcl-2- and
Bcl-xL-overexpressing HeLa cells were either sham or
CVB3 (m.o.i. 10) infected and cell lysates were collected
10 h postinfection. Overexpression of Bcl-2 and Bcl-xL was
confirmed by immunoblot analysis (Fig. 2A). Bcl-2 and
Bcl-xL prevented the release of cyt c, processing of
caspase-2, -3, -7, -8, -9, and PARP, measured at 10 h
following CVB3 infection (Fig. 2B). DEVD(Asp-Glu-Val-
Asp)ase-like cleavage activity in total cell lysates peaked in
neo cells 12 h postinfection and decreased in activity there-
after, but was completely inhibited in both Bcl-2 and Bcl-xL
cells (Fig. 2C). These results confirm that CVB3-induced
apoptosis is initiated by mitochondrial release of apopto-
genic molecules such as cyt c.
Overexpression of Bcl-2 and Bcl-xL inhibits CVB3-
induced mitochondrial membrane protein expression
To further determine mitochondrial function following
CVB3 infection, we examined the expression of the mito-
chondrial epitope 7A6 in cells infected with CVB3 and
exposed to TRAIL. Neo, Bcl-2, and Bcl-xL overexpressing
cells were exposed to a gradient of TRAIL treatments for
24 h and 150 ng/ml was determined to be an ideal concen-
tration to induce Neo cell apoptosis (data not shown). We
used Apo 2.7 antibodies, which reacts with a 38-kDa mito-
chondrial membrane protein (7A6 antigen) expressed as an
early event in apoptosis (Zhang et al., 1996). Expression of
the mitochondrial epitope 7A6 was induced by TRAIL (150
ng/ml) in Neo cells and blocked by zVAD.fmk treatment,
and Bcl-2 and Bcl-xL overexpression (Fig. 3). Infection by
CVB3 induced 7A6 expression in Neo cells which was
unaffected by zVAD.fmk treatment but exhibited nearly a
complete ablation, with Bcl-2 and Bcl-xL (Fig. 3). These
observations suggest that CVB3-induced apoptosis is de-
pendent on mitochondrial alterations upstream of caspase
activity. Uninfected Neo, Neo, and zVAD.fmk, Bcl-2, and
Bcl-xL cells did not exhibit any basal level of 7A6 expres-
sion.
Overexpression of Bcl-2 and Bcl-xL enhances cell
viability
To examine the effect of Bcl-2 and Bcl-xL expression on
CVB3-induced target cell death, we examination cell via-
bility over 18 h, as measured by the 3,[4,5-dimethylthiazol-
2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay. We
demonstrate that zVAD.fmk, and Bcl-2 and Bcl-xL overex-
pression, significantly reduced cell death following virus
infection (Fig. 4A). As compared to a complete loss in cell
viability following infection with CVB3 alone, treatment
with zVAD.fmk reduced loss in cell viability to approxi-
mately 45%. Expression of Bcl-2 and Bcl-xL also preserved
overall viability at approximately 70 and 60%, respectively.
Mitochondrial release of caspase-independent proapoptotic
molecules such as AIF and Endo G may account for the
increased cell viability for Bcl-2 and Bcl-xL overexpression
as compared to zVAD.fmk following CVB3 infection. Cell
viability may not be directly related to CPE as characterized
by the apoptotic phenotype of cell shrinking, rounding, and
eventual detachment from the culture surface despite treat-
ment with zVAD.fmk or expression of Bcl-2 and Bcl-xL as
compared to Neo cells alone (Fig. 4B). Thus, cell viability
is partially dependent on mitochondria-mediated apoptosis
which can be rescued by Bcl-2 and Bcl-xL expression and
by zVAD.fmk.
Enforced expression of Bcl-2 and Bcl-xL only partially
restored cell viability following addition of TRAIL as com-
pared to Neo cells (Fig. 4C). However, Bcl-2 and Bcl-xL
expression did preserve cellular morphology, thus cell via-
bility and morphology are separate phenomena. The inabil-
ity of Bcl-2 and Bcl-xL to completely prevent TRAIL-
induced cell death confirms that receptor-mediated cell
death is only partially mitochondria-dependent.
Overexpression of Bcl-2 and Bcl-xL prevents viral release
We used immunoblot to probe for virus VP1 expression
and found that there was no change in VP1 expression
between Neo and Bcl-2 and Bcl-xL overexpressing cells
10 h p.i. (Fig. 5A). Treatment with the general caspase
inhibitor zVAD.fmk, or Bcl-2 and Bcl-xL expression,
showed a decrease in the amount of progeny virus released
from the supernatant at 10 h p.i. as determined by plaque
assay. Plaque assay for infectious virus on intracellular
extracts confirms that the decrease in released virus is ac-
counted for by an increase in cytoplasmic virus (Fig. 5B).
Bcl-2 and Bcl-xL overexpression and zVAD.fmk reduction
of extracellular virus suggest that host cell apoptosis facil-
itates the release of progeny virus from infected cells.
Discussion
Viruses may either prevent host cell death by expression
of antiapoptotic viral proteins (Teodoro and Branton, 1997;
Granville et al., 1998) or benefit by the initiation of rapid
cell death following infection. Picornaviruses have a short
replication life cycle and are thus capable of quickly para-
sitizing the host and controlling normal cellular functions.
Host transcription and translation are inhibited to allow for
maximal use of host accessory factors for viral RNA tran-
scription and polyprotein translation. Within hours of infec-
150 C.M. Carthy et al. / Virology 313 (2003) 147–157
tion, infectious progeny virus can be detected in the cytosol
of the host cell. Thus, it is becoming evident that apoptosis
in picornavirus-infected cells may be a process triggered or
accelerated by the virus to facilitate viral progeny release.
Activation of the apoptotic machinery can be demon-
strated in tissue culture following picornavirus infection
(Carthy et al., 1998). We further demonstrate that in addi-
tion to caspase-3 activation, PARP, and lamin A/C cleav-
Fig. 2. Bcl-2 and Bcl-xL overexpression prevents cyt c release and processing and activation of multiple caspases. Neo, Bcl-2, and Bcl-xL overexpressing
HeLa cells were either CVB3 (m.o.i. 10) or sham infected and assessed for caspase cleavage and activation. Cytosolic extracts were assessed for (A) presence
of Bcl-2 and Bcl-xL and (B) cytochrome c release from the intermitochondrial membrane space to the cytosol, multiple caspase activation, and cleavage of
PARP at 10 h following CVB3 infection. (C) Neo cells, Bcl-2 overexpressing HeLa cells, and Bcl-xL overexpressing HeLa cells were infected with CVB3
(m.o.i. 10), harvested 0–14 h postinfection, and submitted for DEVDase-like cleavage activity assay.
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age, multiple members of the caspase family are activated.
Apoptosis-related caspases -2, -3, -6, -7, -8, and -9 are all
activated or degraded into their characteristic large and
small subunit components during CVB3 infection. Effector
caspases -3, -6, and -7 are cleaved and activated as shown
by substrate cleavage including PARP, a nuclear protein
involved in DNA repair, and Lamin A/C, a structural pro-
tein. Caspase-8 and -3 can process Bid (Bossy-Wetzel and
Green, 1999; Li et al., 1998) and caspase-9 can activate
caspase -3, -6, or -7 (Pan et al., 1998). To show that
apoptosis signaling is not confined to HeLa cells, we show
that CVB3-infected murine atrial cardiomyocytes also ex-
hibit caspase-3 cleavage late during the infectious process.
Once caspases are activated, a rapid proteolytic cascade
occurs and the cell is quickly dismantled and prepared for
phagocytosis.
Caspases can cleave multiple substrates to regulate trans-
lation, transcription, DNA synthesis and repair, stress sig-
naling, and to disrupt the cellular cytoskeleton by degrada-
tion of important structural proteins. Data presented here
suggest that caspase activation in picornavirus-infected cells
enhances viral release from cells. Such a consequence
would support the virus life cycle by allowing the virus to
find a new host cell and possibly to decrease the ability of
the host to circumvent a virus-induced mobilization of a
nonspecific immune response. Further caspase activation
would decrease inflammation, since molecules such as
phosphatidylserine expressed on apoptotic cells are known
to induce rapid phagocytosis with limitation of inflamma-
tion.
Mitochondria are central regulators of caspase activation
during picornavirus infection. Cyt c is released and initiator
caspase-9 activation may occur through cytosolic pro-
caspase-9, which suggests that this is an important event in
CVB3-induced apoptosis. Cytoplasmic cyt c can associate
with Apaf-1 in the presence of dATP and trigger caspase-9
autocatalysis. Activated capase-9 may either be cytosolic
pro-caspase-9 which is recruited to or activated by the
apoptosome or be mitochondrially sequestered procaspase-9
that is released with cyt c, or a combination of both. Anti-
7A6 defines an epitope on the mitochondrial membrane
protein that appears to be exposed on cells undergoing
apoptosis (Zhang et al., 1996). We demonstrate here that
expression of the mitochondrial epitope 7A6 following in-
fection occurs despite zVAD.fmk treatment; thus, it is un-
likely that mitochondrial permeability transition occurs fol-
lowing Bid processing by caspase-8 or -3. The synthetic
general caspase inhibitor zVAD.fmk does not inhibit
caspase-2 nor does it have any effect on downstream
caspase-independent events. In our infection model, pro-
cessing of caspase-8, -2, and -3 is a relatively late event. In
addition, since zVAD.fmk did not affect mitochondrial ex-
pression of 7A6, CVB3-mediated mitochondrial alterations
are likely upstream of caspase-dependent pathways.
TRAIL is a death ligand that binds to death domain
containing TRAIL-R1 and TRAIL-R2, induces oligomer-
ization, recruitment of adaptor proteins, and subsequent
caspase activation (Schulze-Osthoff et al., 1998). Contrary
to infection by CVB3, TRAIL induces processing of
caspase-8 and subsequent cyt c release and processing of
executioner caspases, as well as mitochondrial membrane
alterations and expression of the 7A6 epitope.
As alluded to earlier, there are several proapoptogenic
materials that have been identified in addition to cyt c such
as AIF, procaspase-2, -3, and -9, Smac/DIABLO, Endo G,
HtrA2/Omi, and others, which are normally sequestered
within the mitochondria. As previously shown, cell viability
was only partially restored with general caspase inhibition
(Carthy et al., 1998). Taken together, proapoptogenic mol-
ecules such as AIF and Endo G which translocate to the
nucleus and induce DNA fragmentation in a caspase-inde-
pendent manner may be involved (Li et al., 2001; Susin et
al., 1996). Other mitochondrial alterations induced during
picornavirus infection may relate to apoptotic signaling;
previous studies have demonstrated the generation of reac-
tive oxygen species (Hiraoka et al., 1993), downregulation
of various mitochondrial transcripts (Taylor et al., 2000),
and a decrease in ATP levels (Waldenstrom et al., 1993).
The Bcl-2 and Bcl-xL are antiapoptotic molecules which
are localized to mitochondrial, endoplasmic reticular, and
nuclear membranes (Tsujimoto and Shimizu, 2000). We
found that overexpression of Bcl-2 and Bcl-xL prevented
cyt c release from the mitochondria to the cytosol for at least
the first 10 h following infection in HeLa cells. This inhi-
bition of cyt c release delays and decreases DEVDase-like
cleavage activity. However, incomplete preservation of
morphology suggests cell bursting during viral release, in-
hibition of host transcription and translation, and loss of
Fig. 3. Bcl-2 and Bcl-xL overexpression but not zVAD.fmk decreases
CVB3-induced 7A6 expression. Neo cells, neo cells treated with zVAD.
fmk, Bcl-2 overexpressing HeLa cells, and Bcl-xL overexpressing HeLa
cells were either infected with CVB3 (m.o.i. 10) for 10 h, exposed to
TRAIL (150 ng/ml) for 2 h, or control treated, and flow cytometry with
APO2.7 was utilized to detect the mitochondrial epitope 7A6.
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Fig. 4. Bcl-2 and Bcl-xL overexpression and zVAD.fmk restores cell viability but not cytopathic effect. Neo cells, neo cells treated with zVAD.fmk, Bcl-2
overexpressing HeLa cells, and Bcl-xL overexpressing HeLa cells were either infected with CVB3 (m.o.i. 10) or sham infected. (A) Cell viability was
measured by MTT dye reduction assay and (B) morphological analysis by differential interference contrast microscopy. (C) Neo cells, Bcl-2, and Bcl-xL
overexpressing HeLa cells were exposed to TRAIL (0–500 ng/ml) and MTT analysis was performed at 24 h. Morphological analysis by differential
interference contrast microscopy of Neo cells, Bcl-2 overexpressing HeLa cells, and Bcl-xL overexpressing HeLa cells was also performed at 0 and 2 h
postinduction.
cellular homeostasis due to direct viral protease cleavage of
structural proteins likely also contribute to the observed
apoptosis phenotype. Indeed, it has been shown that picor-
naviral proteases cleave structural proteins early during in-
fection (Badorff et al., 1999; Seipelt et al., 2000). Protease
2A cleavage of dystrophin disconnects the cytoskeleton
from the extracellular matrix anchor, completely disrupting
the cytoskeletal architecture (Badorff et al., 2000a, 2000b).
Recently, Xiong et al., (2002) showed that such disruption
facilitates virus release from target cells which may occur
through membrane destabilization. This does not mean that
all morphological changes seen during picornavirus infec-
tion are independent of caspases. Many structural changes
noted during electron microscopic evaluation of picornavi-
rus infected cells are characteristic of apoptosis (McManus
et al., 1993).
Overexpression of Bcl-2 and Bcl-xL or caspase inhibi-
tion had no effect on virus replication as there was no
change in expression of viral capsid protein VP1. However,
they did block virus release from infected cells as shown by
a decrease in virus release and a simultaneous increase in
intracellular virus as compared to infection of Neo cells
alone. This data suggest that host-cell apoptosis does not
affect virus replication per se but is necessary for efficient
progeny virus egress. Since activated caspases can upset
cellular architecture, host apoptosis and associated cytoskel-
etal and membranous disruption is likely a viral mechanism
to facilitate maximum virus spread.
In conclusion, we present evidence that mitochondrial
disruption and caspases play a role in loss of functionality
and viability of cells during picornavirus infection, which is
inhibited by expression of Bcl-2 and Bcl-xL. It is clearly
evident that numerous cellular processes are occurring in a
cytopathic cell including activation of apoptotic proteolytic
machinery. These data suggest a direct role for activation of
caspases in the loss of viability and facilitation of efficient
progeny virus release following CVB3 infection.
Materials and methods
Cells, virus, reagents, and antibodies
HeLa cells were obtained from the ATCC. Cells were
grown in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 100 U/ml penicillin, 100 U/ml strepto-
mycin, 2 mM L-glutamine, 1 mM HEPES buffer, and 10%
heat-inactivated fetal bovine serum (FBS). HeLa cells over-
expressing Bcl-2 and Bcl-xL were generated as previously
described (Vander Heiden et al., 1997). Briefly, Bcl-2 and
Bcl-xL inserts were cloned into EcoRI site of pSFFV-Neo
vector (Fuhlbrigge et al., 1988). Vectors containing inserts,
or no insert, were transfected into HeLa cells by electropo-
ration. After selection with 1 g/ml G418 (Gibco, BRL Life
Technologies), cells were cloned by limiting dilution and
transfectants screened for Bcl-xL or Bcl-2 by Western blot.
Transfected cell lines were maintained in complete DMEM
with 1 g/ml G418.
HL-1 cells (murine atrial cardiomyocyte cells) were a
generous gift from Dr. William C. Claycomb (Louisiana
State University Medical Center, New Orleans, LA). Cells
were plated onto fibronectin and gelatin-coated flasks as
described previously (Claycomb et al., 1998) and main-
tained in Claycomb media from JRH Biosciences (Lenexa,
KS) supplemented with 100 U/ml penicillin, 100 U/ml
streptomycin, 2 mM L-glutamine, 0.1 mM norepinephrine in
ascorbic acid, and 10% FBS. Prior to infection, HL-1 cells
were grown to 80% confluency in serum-free media and
infected as above.
Stock CVB3 was generously provided by Dr. Charles
Gauntt (University of Texas Health Sciences Center, San
Antonio, TX). Virus was propagated in HeLa cells and
stored at80°C, and titers were routinely determined at the
beginning of all experiments.
Fig. 5. Bcl-2 and Bcl-xL overexpression and zVAD.fmk prevents viral
release. Neo cells, neo cells treated with zVAD.fmk, Bcl-2-overexpressing
HeLa cells, and Bcl-xL overexpressing HeLa cells were infected with
CVB3 (m.o.i. 10). At 10 h postinfection, (A) immunoblot analysis was
performed using an antibody directed against the viral capsid protein VP1
and (B) plaque assay was utilized for determination of intracellular and
extracellular virus titers.
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The general caspase inhibitor benzyloxycarboyl-Val-
Ala-Asp-fluoromethyl ketone (zVAD.fmk) was purchased
from BACHEM (Bubendorf, Switzerland) and diluted to a
stock concentration of 100 mM in DMSO. All other sup-
plies were purchased from Sigma Chemical Co. (St. Louis,
MO) unless otherwise specified.
Antibodies to cyt c, caspase-2, cleaved caspase-3, and
caspase-9 were purchased from Pharmingen (San Diego,
CA). Antibodies to caspases-6 and -8 were from Upstate
Biotechnology, Inc. (Lake Placid, NY). Antibody to
caspase-7 was obtained from Transduction Laboratories
(Lexington, KY); caspase-3 was obtained from Santa Cruz
Biotechnology (Santa Cruz, CA) and PARP (mAb C-2-10)
was obtained from BIOMOL (Plymouth Meeting, PA). An-
tibodies to Bcl-2 and Bcl-xL were purchased from Trans-
duction Laboratories and polyclonal CVB3 VP1 antibody
was obtained from Accurate Chemicals (Westbury, NY).
Virus infection
HeLa cells were infected at an m.o.i. of 10 with CVB3 or
sham-treated with DMEM without FBS for 45 min. Cells
were washed with phosphate-buffered saline (PBS) and
complete DMEM containing 10% FBS was replaced. HeLa
cells were exposed to TRAIL (150 ng/ml) for 24 h. Cell
viability was measured using MTT as described below.
Cell lysates, electrophoresis, and Western blotting
Cells were washed twice in cold PBS. For total cell
lysates, cell were suspended in 1 ml of cold lysis buffer (20
mM Tris pH 8, 137 mM NaCl, 10% glycerol, 1% Nonidet
P-40, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml apro-
tinin) per 75-cm2 culture area. After 20 min on ice, super-
natant was collected following centrifugation at 10,000 g.
For cytosolic extracts, cells were washed twice in cold PBS
and resuspended in 1 ml of ice cold buffer (250 mM su-
crose, 20 mM HEPES pH 7.4, 10 mM KCl, 1.5 mM MgCl2,
1 mM EGTA, 1 mM EDTA, 1 mM DTT, supplemented
with 1 mM PMSF and 10 g/ml aprotinin) per 75-cm2
culture area. Cells were disrupted by 20 strokes with the B
pestle of a Kontes dounce homogenizer. The supernatant
was collected following centrifugation at 10,000 g and fur-
ther centrifuged at 100,000 g for 1 h at 4°C in a Beckman
Optima ultracentrifuge using a TL-100 rotor. Cell lysate
protein concentration was determined by the BCA method
(Pierce Chemical Co., Rockford, IL). Samples were sepa-
rated by sodium dodecyl sulfate–polyacrylamide gel elec-
trophoresis (SDS–PAGE). Proteins were transferred to ni-
trocellulose (Hybond ECL, Amersham Pharmacia Biotech,
Uppsala, Sweden). Following blocking and incubation with
primary and secondary antibody, horseradish peroxidase
conjugated secondary immunoglobulins were detected us-
ing the enhanced chemiluminescence (ECL) method (Am-
ersham Pharmacia Biotech) and exposed to Hyperfilm (Am-
ersham Pharmacia Biotech).
Caspase activation assay
To evaluate DEVDase-like (caspase-3 and -7) cleavage
activity following CVB3 infection, total HeLa cell lysates
were incubated with a caspase-specific fluorescent substrate
as previously described (Granville et al., 1997). Briefly,
lysates were incubated with reaction buffer (20 mM Tris pH
7.5, 137 mM NaCl, 1% NP-40, 10% glycerol) containing
100 M of the caspase substrates DEVD-AMC (Calbio-
chem, Cambridge, MA). Reaction mixture was incubated at
37°C for 2 h and fluorescence excitation at 380 nm and
emission at 460 nm was measured using a CytoFluor 2350
from Perseptive Biosystems (Norwalk, CT).
Flow cytometry
At 10 h following CVB3 infection or 2 h following
TRAIL (150 ng/ml) treatment, HeLa cells were washed
twice in cold PBS and dispersed into suspension by gentle
agitation with 2 mM EDTA–PBS. Cells were permeabilized
with 0.1% digitonin in PBS. Cells were exposed to the
phycoerythrin (PE)-conjugated mouse IgG1 monoclonal an-
tibody APO2.7 (Beckman-Coulter, Fullerton, CA) in a so-
lution of PBS containing 2% FCS for 30 min on ice. Control
cells were treated with a PE-conjugated isotype-matched
antibody. Cells were washed twice with the labeling solu-
tion and read immediately on a Coulter XL flow cytometer
(Coulter Electronics, Inc., Hialeah, FL). Mean channel flu-
orescence intensity (MCFI) values were determined (5000
cells analyzed per sample).
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium
bromide) assay
To determine cell viability, cells were cultured in Falcon
96-well microtiter plates and the MTT assay was performed
as previously described (Mosmann, 1983) with modifica-
tions. Briefly, following CVB3 infection culture medium
was decanted and replaced with complete DMEM contain-
ing 10% FBS. At 10 h following CVB3 infection or 24 h
following TRAIL (0–500 ng/ml) treatment, culture medium
was aspirated and 50 g of MTT in 100 l of PBS was
added to each well. Cells were incubated for 1 h and the
reaction was stopped by the addition of 150 l of acidified
isopropanol. Color development correlating to cell viability
was measured at 590 nm with a Dynatech Laboratories
microtiter plate reader (Chantilly, VA).
Plaque assay
The amount of CVB3 in cell supernatant or cytoplasmic
extracts was determined on monolayers of HeLa cells by
agar overlay plaque assay method as previously described
(Anderson et al., 1996). Briefly, sample supernatant was
serially diluted 10-fold and overlaid on 90–95% confluent
monolayers of HeLa cells in six-well plates (Corning
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Costar, Corning, NY) and incubated for 1 h (5% CO2,
37°C). Media containing nonbound virus was removed and
warm complete DMEM containing 0.75% agar was overlaid
in each well. The plates were incubated 36 to 48 h (5% CO2,
37°C), fixed with Carnoy’s fixative (95% EtOH: acetic acid
(3:1)), and stained with 1% crystal violet. The plaques were
counted and the viral concentration was calculated as plaque
forming units (PFU) per milliliter of culture supernatant.
Morphology
Differential interference contrast (DIC) morphological
images were taken with a Nikon Eclipse TE300 inverted
scope (Nikon, Tokyo, Japan) and collected using SPOT
imaging software (Diagnostic Instruments, Inc.; Sterling
Heights, MI).
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